zenocutuzumab
merus
['meru', 'zenocutuzumab', 'mrus', 'merus']
$mrus merus presents clinical data on zenocutuzumab (zeno) in nrg1-fusion (nrg1+) cancer at the 2022 american society of clinical oncology (asco) annual meeting (oral abstract) 
News and analysis of biomedical, biopharma, biotech, biosciences, pharmaceutical, and technology equities